TRAPPC8 Is an Endogenous Brake on UFMylation That Suppresses Tauopathy
WAN, Y.; Cordes, E.; Feng, W.; Lee, S. I.; Munechika, K.; Sun, Y.; Gao, Z.; Gao, B.; Zhu, J.; Wong, M. Y.; Norman, K.; Wang, S.; chen, h.; Liu, B.; Li, Z.; Srinivasan, M.; Amin, S.; Wei, X.; Mok, S.-A.; Shen, R.; Luo, W.; Gong, S.; Li, H.; Yu, H.; Gan, L.
Show abstract
UFMylation, a ubiquitin-like protein modification, drives tau spread through the brain, but what keeps this process in check has remained unclear. We show that TRAPPC8 acts as a natural brake on UFMylation, binding directly to the E1 enzyme UBA5 to dampen pathway activity. In Alzheimer's disease brain tissue, TRAPPC8 is reduced while UFMylation is elevated, suggesting this brake fails as disease progresses. Sustaining UFMylation in human iPSC-derived neurons increased tau aggregation and spread while disrupting lysosomal function and lipid balance. Restoring TRAPPC8-UBA5 binding reversed these defects through the lysosomal protein CLN8, which restored lysosomal function and reduced tau pathology. Notably, expressing just the UBA5-binding region of TRAPPC8 was enough to suppress tau pathology in vivo, marking it as a promising therapeutic target.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Glucose hypometabolism and hyperphosphorylated Tau synergistically drive neuronal necroptosis 97%
- Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model 94%
- Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration 94%
Similar papers in this journal
- TFEB degradation is regulated by an IKK/β-TrCP2 phosphorylation-ubiquitination cascade 97%
- Aβ42 oligomers trigger synaptic loss through CAMKK2-AMPK-dependent effectors coordinating mitochondrial fission and mitophagy 97%
- Single-nucleus epigenomic dysregulation unmasks genetic risk-associated neurodegenerative glia states 96%
Similar papers in this journal
- Tau assemblies enter the cytosol in a cholesterol sensitive process essential to seeded aggregation 96%
- Sustained TREM2 stabilization accelerates microglia heterogeneity and Abeta pathology in a mouse model of Alzheimer s disease 94%
- Small tau aggregates exhibit disease-specific molecular profiles across tauopathies 94%
Similar papers in this journal
- Tau pathology spreads between anatomically-connected regions of the brain and is modulated by a LRRK2 mutation 94%
- Neurons burdened by DNA double strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. 93%
- Lysosomal dysfunction in Down Syndrome and Alzheimer mouse models is caused by selective v-ATPase inhibition by Tyr682 phosphorylated APP βCTF 93%
Similar papers in this journal
- C9orf72/SMCR8 complex maintains microglial homeostasis via RAB8A-ESCRT-mediated lysosomal repair 97%
- Structural polymorphism of alpha-synuclein fibrils alters pathway of Hsc70 mediated disaggregation 93%
- The structural and biophysical basis of substrate binding to the hydrophobic groove in Ubiquilin Sti1 domains 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.